Microvascular and cellular dysfunctions in Alzheimer’s disease: an integrative analysis perspective-Reference-Cited by-同舟云学术

Microvascular and cellular dysfunctions in Alzheimer’s disease: an integrative analysis perspective

Published:2024-09-09 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Mengjie,Hao Xiaoyan,Hu Zhengwei,Tian Jie,Shi Jingjing,Ma Dongrui,Guo Mengnan,Li Shuangjie,Zuo Chunyan,Liang Yuanyuan,Tang Mibo,Mao Chengyuan,Xu Yuming,Shi Changhe

Funder

the Scientific and Technological Research Projects in Henan province

National Natural Science Foundation of China

Funding for Scientific Research and Innovation Team of the First Affiliated Hospital of Zhengzhou University

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-71888-0.pdf

Reference79 articles.

1. Scheltens, P. et al. Alzheimer’s disease. Lancet 397, 1577–1590. https://doi.org/10.1016/s0140-6736(20)32205-4 (2021).

2. Hardy, J. & Selkoe, D. J. The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science 297, 353–356. https://doi.org/10.1126/science.1072994 (2002).

3. Maccioni, R. B., Farías, G., Morales, I. & Navarrete, L. The revitalized tau hypothesis on Alzheimer’s disease. Arch. Med. Res. 41, 226–231. https://doi.org/10.1016/j.arcmed.2010.03.007 (2010).

4. Terry, A. V. Jr. & Buccafusco, J. J. The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306, 821–827. https://doi.org/10.1124/jpet.102.041616 (2003).

5. Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 14, 133–150. https://doi.org/10.1038/nrneurol.2017.188 (2018).